51例伴不同浸润程度卵巢交界性肿瘤临床病理分析

《51例伴不同浸润程度卵巢交界性肿瘤临床病理分析》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、-------华中科技大学硕士学位论文diameteroftumorswere10.4cm，11.4cmand14.7cm，andthemediumvolumeswere394.21ml，540.3mland1084.3ml;25%，7/8and78.9%oftumorsdisplayedrichbloodflow.54.2%，4/8and78.9%ofpatientshadabnormaltumormarkers.Forserousborderlinetumorsandendometrialborderli

2、netumors,themediumCA-125were44.2U/ml，33.1U/ml，189.6U/ml.Allpatientsreceivedoperation;FIGOstageIwere41.7%，6/8and57.9%;41.7%，5/8and36.8%receivedconservativeoperation;41.7%，1/8and26.3%hadrestagingproceduresand5/10，0/1，2/5ofthemwereupstaged.21,6,19patientshadpe

3、lviclymphnodedissectionwithorwithoutpara-aorticlymphnodedissection,38.1%,1/6,5.2%werelymphnodepositive.Theaccuracyoffrozensectionwas54.3%,thesensitivitywas90.4%andthepositivepredictivevaluewas61.2%;noneoftheBOT-LGEOCwerediagnosedduringoperations.Positiverat

4、eofVEGFwere42.8%,4/7and50%.45.8%,7/8and89.4%ofpatientshadchemotherapy.For22caseswhoreceivedconservativeoperations,3caseshadshortermenstrualcyclesafterwards.For10patientswhohadfamilyplans,threepatientshadfivepregnanciesandthreefull-termdeliveries.Twopatients

5、recurred.Conclusions：BOTisconsistedofacontinuumofdiseases.MakingaccuratediagnosisofBOT-LGEOCisdifficultduringoperations.Forpatientswhohaveabnormaltumormarkersandsometypicalultrasoundmanifestations,adiagnosisofBOT-LGEOCcannotbeoverlooked.Thereisnodifferenceo

6、fexpressionofVEGFinBOTwithdifferentlevelsofinvasion.Forpatientswithfamilyplans,aconservativeoperationmightbeconsideredregardlessoftheirstages.Avoidanceofperformingcystectomymightlowerrecurrencerate.【Keywords】borderlineovariantumor；micro-invasion；micro-papil

7、lary；VascularEndothelialGrowthFactor，VEGF4-----------华中科技大学硕士学位论文前言卵巢交界性肿瘤(borderlineovariantumor，BOT)的概念最早来自1929年Taylor基于纽约医院卵巢肿瘤临床经验所做的观察性报道［1］，他注意到某些上皮性肿瘤，即使腹腔内已广泛播散，其临床行为仍呈良性，与其他发生播散后迅速致死的上皮性癌明显不同，并将其命名为“一半恶性”（semi-malignant）。长期以来对BOT的命名及病理诊断标准一直存在不同的意见

8、，对其治疗更是存在较多争议。在上世纪70［2］和WHO［3］相继制定出BOT的诊断标准，将 年代早期，国际妇产科联盟（FIGO）其定义为“具有某些恶性肿瘤的形态学特点，但无破坏性的间质浸润”。经过30余年的探索，对其本质认识逐步深入，特别是2003年8月在美国马里兰州贝塞斯达举行［4］，就BOT的某些病理学方面的分歧取得了较一致的意见。既往 的BOT工作会议观点认为BOT是一类同质性（homogen